These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26599419)

  • 21. Protein structures in virtual screening: a case study with CDK2.
    Thomas MP; McInnes C; Fischer PM
    J Med Chem; 2006 Jan; 49(1):92-104. PubMed ID: 16392795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using pharmacophore models to gain insight into structural binding and virtual screening: an application study with CDK2 and human DHFR.
    Toba S; Srinivasan J; Maynard AJ; Sutter J
    J Chem Inf Model; 2006; 46(2):728-35. PubMed ID: 16563003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vibrational softening of a protein on ligand binding.
    Balog E; Perahia D; Smith JC; Merzel F
    J Phys Chem B; 2011 Jun; 115(21):6811-7. PubMed ID: 21553905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α.
    Perricone U; Wieder M; Seidel T; Langer T; Padova A; Almerico AM; Tutone M
    ChemMedChem; 2017 Aug; 12(16):1399-1407. PubMed ID: 28135036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In pursuit of virtual lead optimization: pruning ensembles of receptor structures for increased efficiency and accuracy during docking.
    Bolstad ES; Anderson AC
    Proteins; 2009 Apr; 75(1):62-74. PubMed ID: 18781587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration.
    Tosso RD; Andujar SA; Gutierrez L; Angelina E; Rodríguez R; Nogueras M; Baldoni H; Suvire FD; Cobo J; Enriz RD
    J Chem Inf Model; 2013 Aug; 53(8):2018-32. PubMed ID: 23834278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the Stability of Ligand Binding Modes to Proteins by Molecular Dynamics Simulations: A Cross-docking Study.
    Liu K; Kokubo H
    J Chem Inf Model; 2017 Oct; 57(10):2514-2522. PubMed ID: 28902511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of site-directed spin labeling for characterizing protein-ligand complexes using simulated restraints.
    Constantine KL
    Biophys J; 2001 Sep; 81(3):1275-84. PubMed ID: 11509344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BEAR, a novel virtual screening methodology for drug discovery.
    Degliesposti G; Portioli C; Parenti MD; Rastelli G
    J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ligand binding on the intraminimum dynamics of proteins.
    Alakent B; Baskan S; Doruker P
    J Comput Chem; 2011 Feb; 32(3):483-96. PubMed ID: 20730777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
    Huang SY; Zou X
    Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking.
    May A; Zacharias M
    J Med Chem; 2008 Jun; 51(12):3499-506. PubMed ID: 18517186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Conformational Flexibility on Binding Free Energy Estimation between Kinases and Their Inhibitors.
    Araki M; Kamiya N; Sato M; Nakatsui M; Hirokawa T; Okuno Y
    J Chem Inf Model; 2016 Dec; 56(12):2445-2456. PubMed ID: 28024406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Definitive Pharmacophore Modelling Study on CDK2 ATP Pocket Binders: Tracing the Path of New Virtual High-Throughput Screenings.
    Tutone M; Culletta G; Livecchi L; Almerico AM
    Curr Drug Discov Technol; 2020; 17(5):740-747. PubMed ID: 31250757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flexible receptor docking for drug discovery.
    Wong CF
    Expert Opin Drug Discov; 2015; 10(11):1189-200. PubMed ID: 26313123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher Accuracy Achieved for Protein-Ligand Binding Pose Prediction by Elastic Network Model-Based Ensemble Docking.
    Wang A; Zhang Y; Chu H; Liao C; Zhang Z; Li G
    J Chem Inf Model; 2020 Jun; 60(6):2939-2950. PubMed ID: 32383873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Characterization of Dihydrofolate Reductase Complexes by Top-Down Ultraviolet Photodissociation Mass Spectrometry.
    Cammarata MB; Thyer R; Rosenberg J; Ellington A; Brodbelt JS
    J Am Chem Soc; 2015 Jul; 137(28):9128-35. PubMed ID: 26125523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the conformational space of a receptor for drug design: An ERα case study.
    Schneider M; Pons JL; Labesse G
    J Mol Graph Model; 2021 Nov; 108():107974. PubMed ID: 34274728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of indole derivatives as the potent anticancer agents on dihydrofolate reductase: pharmaco-informatics and molecular dynamics simulation.
    Abdolmaleki B; Maddah M
    J Biomol Struct Dyn; 2023 May; 41(8):3667-3679. PubMed ID: 35318890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional role for Tyr 31 in the catalytic cycle of chicken dihydrofolate reductase.
    Shrimpton P; Mullaney A; Allemann RK
    Proteins; 2003 May; 51(2):216-23. PubMed ID: 12660990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.